Sledování účinku atorvastinu na proces aterogeneze u apoE-/-/LDLR-/ - double knock-out myšího modelu aterosklerózy III.

Atherosclerosis is a chronic inflammatory disease of blood vessels with a successive, very slow progress which takes many years and ,,plugs"disabled vessels. Faults and changes in representation and quantity of lipoproteins are for this disease very typical. In human medicine is mostly used med...

Full description

Bibliographic Details
Main Author: Slanařová, Martina
Other Authors: Nachtigal, Petr
Format: Dissertation
Language:Czech
Published: 2008
Online Access:http://www.nusl.cz/ntk/nusl-292586
id ndltd-nusl.cz-oai-invenio.nusl.cz-292586
record_format oai_dc
spelling ndltd-nusl.cz-oai-invenio.nusl.cz-2925862017-09-02T04:15:55Z Sledování účinku atorvastinu na proces aterogeneze u apoE-/-/LDLR-/ - double knock-out myšího modelu aterosklerózy III. Studying of atorvastatin effects lipid profile in mice models of atherosclerosis. Slanařová, Martina Nachtigal, Petr Hyšpler, Radomír Atherosclerosis is a chronic inflammatory disease of blood vessels with a successive, very slow progress which takes many years and ,,plugs"disabled vessels. Faults and changes in representation and quantity of lipoproteins are for this disease very typical. In human medicine is mostly used medication Statins during a therapy of dyslipoproteinemia. The aim is this thesis was to describe the changes of biochemical lipoproteins levels at the various mice models of atherosclerosis. Furthermore we wanted to describe the changes lipids after administering of atorvastatin in apoE-defitient mice and apoE/LDLr-deficient mice. Female of apoE-deficient mice and apoE/LDLr-deficient mice were divided into a control and with atorvastatin treated group, where atorvastatin was administered in a period of 8 weeks in a dose of 100 mg/kg mouse. Biochemical analysis of lipids was performed by a separation method of lipoproteins by means of ultracentrifugal technique. Biochemical analysis of blood of apoE-deficient mice demonstrated, that 8 weeks atorvastatin treatment in a dose of 100 mg/kg significantly increased levels of total cholesterol, VLDL, LDL and HDL cholesterol. The blood analysis of apoE/LDLr-deficient mice demonstrated, that 8 weeks long treatment with atorvastatin in the same doses significantly reduced... 2008 info:eu-repo/semantics/masterThesis http://www.nusl.cz/ntk/nusl-292586 cze info:eu-repo/semantics/restrictedAccess
collection NDLTD
language Czech
format Dissertation
sources NDLTD
description Atherosclerosis is a chronic inflammatory disease of blood vessels with a successive, very slow progress which takes many years and ,,plugs"disabled vessels. Faults and changes in representation and quantity of lipoproteins are for this disease very typical. In human medicine is mostly used medication Statins during a therapy of dyslipoproteinemia. The aim is this thesis was to describe the changes of biochemical lipoproteins levels at the various mice models of atherosclerosis. Furthermore we wanted to describe the changes lipids after administering of atorvastatin in apoE-defitient mice and apoE/LDLr-deficient mice. Female of apoE-deficient mice and apoE/LDLr-deficient mice were divided into a control and with atorvastatin treated group, where atorvastatin was administered in a period of 8 weeks in a dose of 100 mg/kg mouse. Biochemical analysis of lipids was performed by a separation method of lipoproteins by means of ultracentrifugal technique. Biochemical analysis of blood of apoE-deficient mice demonstrated, that 8 weeks atorvastatin treatment in a dose of 100 mg/kg significantly increased levels of total cholesterol, VLDL, LDL and HDL cholesterol. The blood analysis of apoE/LDLr-deficient mice demonstrated, that 8 weeks long treatment with atorvastatin in the same doses significantly reduced...
author2 Nachtigal, Petr
author_facet Nachtigal, Petr
Slanařová, Martina
author Slanařová, Martina
spellingShingle Slanařová, Martina
Sledování účinku atorvastinu na proces aterogeneze u apoE-/-/LDLR-/ - double knock-out myšího modelu aterosklerózy III.
author_sort Slanařová, Martina
title Sledování účinku atorvastinu na proces aterogeneze u apoE-/-/LDLR-/ - double knock-out myšího modelu aterosklerózy III.
title_short Sledování účinku atorvastinu na proces aterogeneze u apoE-/-/LDLR-/ - double knock-out myšího modelu aterosklerózy III.
title_full Sledování účinku atorvastinu na proces aterogeneze u apoE-/-/LDLR-/ - double knock-out myšího modelu aterosklerózy III.
title_fullStr Sledování účinku atorvastinu na proces aterogeneze u apoE-/-/LDLR-/ - double knock-out myšího modelu aterosklerózy III.
title_full_unstemmed Sledování účinku atorvastinu na proces aterogeneze u apoE-/-/LDLR-/ - double knock-out myšího modelu aterosklerózy III.
title_sort sledování účinku atorvastinu na proces aterogeneze u apoe-/-/ldlr-/ - double knock-out myšího modelu aterosklerózy iii.
publishDate 2008
url http://www.nusl.cz/ntk/nusl-292586
work_keys_str_mv AT slanarovamartina sledovaniucinkuatorvastinunaprocesaterogenezeuapoeldlrdoubleknockoutmysihomodeluaterosklerozyiii
AT slanarovamartina studyingofatorvastatineffectslipidprofileinmicemodelsofatherosclerosis
_version_ 1718525177156861952